Cargando…
MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model
Costello syndrome (CS) is a congenital disorder caused by heterozygous activating germline HRAS mutations in the canonical Ras/mitogen-activated protein kinase (Ras/MAPK) pathway. CS is one of the RASopathies, a large group of syndromes caused by mutations within various components of the Ras/MAPK p...
Autores principales: | Tidyman, William E., Goodwin, Alice F., Maeda, Yoshiko, Klein, Ophir D., Rauen, Katherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617311/ https://www.ncbi.nlm.nih.gov/pubmed/34553752 http://dx.doi.org/10.1242/dmm.049166 |
Ejemplares similares
-
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer
por: Hartung, Anne-Mette, et al.
Publicado: (2016) -
Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model
por: Nandi, Sayantan, et al.
Publicado: (2022) -
HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models
por: Dard, Laetitia, et al.
Publicado: (2022) -
Neonatal Lethal Costello Syndrome and Unusual Dinucleotide Deletion/Insertion Mutations in HRAS Predicting p.Gly12Val
por: Burkitt-Wright, Emma MM, et al.
Publicado: (2012) -
Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review
por: Qian, Wen, et al.
Publicado: (2021)